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Summary.-The specific lung-AHH induction, which we previously observed after
the inhalation of cigarette smoke, is not due to the route followed by the inhaled
smoke, for the same phenomenon occurs after i.p. injection of either cigarette smoke
condensate (CSC) or benzo(a)pyrene in low doses. In this respect lung AHH behaves
completely differently from the liver and kidney enzyme, in which organs, basal AHH
activity (which is low in the foetus) increases rapidly after birth to reach the adult
level 2 months later, and is only inducible by CSC and low doses of BP in unweaned
rats.
In the lung, the basal AHH activity (low in the foetus) increases abruptly at birth,
peaks in 5-day-old rats and then decreases slightly. Contrary to enzyme activity in
other tissues, lung AHH cannot be induced in unweaned young animals. The enzyme
subsequently becomes sensitive to inducing agents and is highly inducible in 90-day-
old rats.
Similar behaviour occurs in 2 other enzymes linked to cytochrome P1450: ethoxy-
coumarin deethylase and ethoxyresorufin deethylase. The results could be related to
the particular susceptibility of the lung to develop cancer after the inhalation of
cigarette smoke.
MOST CHEMICAL CARCINOGENS are harm-
less lipophilic molecules which cannot be
eliminated from the body unless they are
transformed into more polar, hydrosoluble
metabolites. This transformation is cata-
lysed by the successive action of micro-
somal monooxygenases, epoxide hydrolase
and conjugating enzymes such as sulpho-
transferase, UDP-glucuronyl transferase
or glutathione transferase (Heidelberger,
1975; Miller & Miller, 1976; Weisburger,
1978; Gielen, 1978).
The first enzymic reaction of the poly-
cyclic-hydrocarbon metabolic pathway is
catalysedbyacytochromeP450-dependent
monooxygenase, the aryl hydrocarbon
hydroxylase (AHH). This leads to the
formation of reactive arene oxides, which
are further metabolized by enzymic and
non-enzymic reactions into many metabo-
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lites (DePierre & Ernster, 1978). These
reactive intermediates could also bind
covalently to cellular macromolecules,
and generate a variety of toxic effects
inducing mutations and cancer (Heidel-
berger, 1975; Miller & Miller, 1976; Weis-
burger, 1978; Nebert & Jensen, 1979). To
measure the activity of the AHH, it is
necessary to quantitate all the metabo-
lites, as they are all derived from the arene
oxides initially produced by the AHH.
This assay can only be performed accur-
ately by an isotopic method which uses
[3H]-benzo(a)pyrene as a substrate of the
enzyme reaction (Van Cantfort et al.,
1977).
Cigarette smoke appears to be one ofthe
commonest carcinogenic products of our
environment. Numerous epidemiological
studies have shown an increase in theONTOGENETIC VARIATION IN MONOOXYGENASE INDUCTION
incidence of cancer in several organs,
notably the lung, among cigarette smokers
(Wynder & Mabuchi, 1972; Doll, 1977;
1978). This phenomenon has been experi-
mentally reproduced in several animals or
in vitro models (Akin et al., 1976; Kouri
et al., 1979; Florin etal., 1980).
This particular susceptibility of the
lung to initiate cancer on exposure to
cigarette smoke could be due to several
factors: (a) substances in cigarette smoke
which induce monooxygenases; (b) the
direct action oftoxic components in smoke
on the first organ reached; (c) numerous
potentially carcinogenic agents in smoke
which can be activatedintohighly reactive
metabolites; (d) the very low activity of
lung conjugating enzymes which catalyse
the elimination ofthese active metabolites
(Ball etal., 1979).
The inducing effect of cigarette smoke is
the best known phenomenon. In man, this
inducing action of cigarette smoke has
been demonstrated in placentas collected
at birth from smoking and non-smoking
women (Nebert et al., 1969; Vaught et al.,
1979) and in the pulmonary alveolar
macrophages of smokers and non-smokers
(Cantrell et al., 1973). In rats, mice and
hamsters, AHH is specifically induced by
cigarette smoke in the lung and kidney
(Abramson & Hutton, 1975; Welch et al.,
1971; Dansette et al., 1979; Bilimoria &
Ecobichon, 1980; Van Cantfort & Gielen,
1977). In both tissues, the maximal effect
has an induction factor of 10, but the lung
enzyme is much more sensitive, since it
demonstrates a greater response to small
doses of cigarette smoke (Van Cantfort &
Gielen, 1977). This induction of mono-
oxygenases leads to the formation of more
active metabolites when the lungis treated
with [3H]-benzo(a)pyrene, and an increase
in its covalent binding to macromolecules
(Cohen etal., 1977).
On the other hand, cigarette smoke has
no action on AHH activity in the liver
(Abramson & Hutton, 1975; Dansette
et al., 1979; Van Cantfort & Gielen, 1977).
This organotropism can be explained by
the particular route followed by cigarette-
smoke components, which, after inhala-
tion, first reach the lung where their con-
centration is obviously the highest. After
absorption into the pulmonary blood, they
go directly to the left side of the heart
and to the kidney where they are filtered
before reaching other tissues such as the
liver.
In this paper, we show that this organo-
tropism is also due to the particular
sensitivity of extrahepatic tissues to the
inducing action of the polycyclic hydro-
carbons in cigarette smoke. Parallel induc-
tion can be obtained by inhaling cigarette
smoke and by i.p. injection of cigarette-
smoke condensate (CSC), or low doses of
BP. We thus demonstrate that three
parameters are important: the concentra-
tion of the polycyclic hydrocarbons ad-
ministered, the age of the animal, and the
organ investigated.
MATERIAL AND METHODS
Benzo(a)pyrene was purchased from Fluka
(New-Ulm, F.R.G.). Aldrin and dieldrin were
from Riedel-de-Haen (Hannover, F.R.G.);
glucose-6-phosphate dehydrogenase and en-
zymic co-factors were from Boehringer
(Mannheim, F.R.G.). CSC was a generous gift
from Dr R. E. Kouri (Microbiological Asso-
ciates, Bethesda, Maryland, U.S.A.). Other
chemicals and solvents were of analytical
grade and were obtained from Merck (Darm-
stadt, F.R.G.). 3H-benzo(a)pyrene (1-2 Ci/
mmol) was purchased from I.R.E. (Fleurus,
Belgium) and 3H-benzo(a)pyrene 4-5 oxide
(2.3 Ci/mmol) was prepared according to the
method of Dansette & Jerina (1974).
Treatment of animals.-All the experi-
ments were performed on Sprague-Dawley
rats obtained from the Centre des Oncins
(Lyon, France). They were kept at a constant
temperature of 22°C with free access to food
(UAR A03, Villemoisson, France) and tap
water.
BP and CSC, dissolved in dimethylsulph-
oxide, were given by 3 successive i.p. injec-
tions at 24h intervals for 3 consecutive days.
Control animals received the same quantity
of the vehicle only (0 5 ml/kg).
The animals were killed by decapitation
24 h after the last injection. The organs were
removed and immediately plunged in cold
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isotonic KCl. Livers, kidneys and lungs were
then pressed through a metallic disc per-
forated with 1-5mm-diameter holes to elimin-
ate the connective tissues. For each organ, the
resulting pulp was diluted with 4 parts of a
Tris (0O01M, pH 7-4) sucrose (0-25M) buffer
and homogenized in a Potter Elvejhem tube
with a teflon pestle. The homogenate was
centrifuged for 10 min at 10,000 g in a re-
frigerated Sorvall (RC 2B) and the super-
natant, stored at -20°C, was used as a source
for enzyme analysis.
Enzyme assays.-AHH activity was meas-
ured by an isotope method developed in our
laboratory (Van Cantfort et at., 1977; Manil
et al., 1981). The measurement of aldrin
epoxidase was performed by the method
described by Wolff et al. (1979). The assays
for ethoxycoumarin deethylase (Aitio, 1978),
ethoxyresorufin deethylase (Burke & Mayer,
1974), aminopyrine-N-demethylase (Christen-
sen & Wissig, 1972), epoxide hydrolase
(Schmassman et al., 1976), and epoxide-
glutathione transferase (Van Cantfort et al.,
1979) have also been described. In each case,
we used the Lowry method to verify that the
treatment did not influence the protein con-
centration ofthe organ.
RESULTS
Specific lung and kidney AHH induction
after i.p. injection of cigarette-smoke
condensate
We previously demonstrated that cigar-
ette-smoke inhalation specifically induces
AHH in the lung and kidney, but has no
effect on the liver enzyme (Van Cantfort
& Gielen, 1977). In order to demonstrate
the importance of the method of adminis-
tering the smoke on the specific induction
ofAHH in extrahepatic organs, we studied
the effect ofi.p. injection ofCSC.
When administered i.p., the chemicals
obviously reached the liver before the
other organs. Nevertheless, the lung was
surprisingly the most sensitive organ,
followed by the kidney and then the liver
(Fig. 1). With a 5mg/kg dose, only the
lung AHH activity was significantly
induced. With a 20mg/kg dose, both the
lung and kidney enzymes were induced,
but only a 50mg/kg dose induced the liver
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FIG. 1.-Effect of i.p. injection of cigarette
smoke condensate on AHH activity in rat
liver, lung and kidney. AHH was measured
in the 9000g supernatant of liver, kidney
and lung homogenates obtained from male
Sprague-Dawley rats (250 g) treated with
the vehicle alone (100 ,ul DMSO; Co) or
with 5, 20 and 50 mg/kg ofcigarette smoke
condensate (CSC). Three successive ad-
ministrations were performed at 24h inter-
vals the rats were killed on the 4th day.
The results correspond to the mean+ s.d.
(vertical bars) from 5 rats. *=P< 0 05 com-
pared to control animals.
enzyme. These results thus repeated the
effects ofthe inhalation ofcigarette smoke.
We thus concluded that the CSC contained
substances with a selective action on
extrahepatic tissues, andnotably, the lung
or that the lung was the most sensitive
tissue to the inducers in CSC.
Ontogenetic variation in liver, kidney and
lung AHH induction after i.p. injections
ofCSC
As shown in Figs 2, 3 and 4, AHH
inducibility varied greatly during the
ontogeny of the animals and was quite
different in the lung compared to the
kidney and liver.
In the liver, CSC, either at a 5mg/kg or
25mg/kg dose, did not induce AHH in the
foetus and in 5-day-old rats. Surprisingly,
in 15-day-old animals, CSC was a very
good inducer of AHH, but this property
rapidly disappeared in older animals, and
was never observed in rats more than
30 days old (datanot shown).
In the kidney, a similar phenomenon
occurred (Fig. 2). AHH was not induced
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FIG. 2.-Effect of i.p. injection of CSC on
rat kidney AHH activity as a function of
age. Rats were treated 3 times at 24h
intervals with CSC (5 or 25 mg/kg) and
killedonthe 4th day. AHH was measured in
the 9000g supernatant. The results show
mean+s.d. from 3 pools of 5 rats (5 and 15
days old), 5 pools of 2 rats (30 days old)
and 5 individual rats (60 and 90 days
old). *P <0 05.
after i.p. injection of CSC in the foetus
or in very young animals. It was well
induced in 15-day-old rats, especially by
the larger dose, but contrary to the liver,
AHH remained slightly inducible by the
25mg/kg dose in the older animals.
In the lung, this ontogenetic variation
of AHH inducibility was quite different
(Fig. 3). AHH was insensitive to the
action of CSC in unweaned animals. Its
inducibility then continuously increased
with age. In fact, from the 15th to the
90th day after birth, the basal AHH
activity in control rats continuously
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FIG. 3.-Effect of i.p. injection of CSC on rat
lung AHH activity as a function of age.
Methodological details as in Fig. 2.
decreased, but the activity induced by a
25mg/kg dose, gradually increased. In
3-month-old rats, the induction factor
thus increased to 4. In older animals,
both basal and induced AHH activities
remained constant, as similar results were
obtained from 9-month-old rats (data not
shown).
Ontogenetic variation in liver, kidney and
lung AHH induction after i.p. injection of
BP
As polycyclic hydrocarbons are gener-
ally considered to be the most powerful
inducers in cigarette smoke, we tested the
effect of one of the main members of this
class: benzo(a)pyrene, though BP is sel-
dom used ininduction experiments in vivo;
preference usually being given to 3-
methylcholanthrene or dimethylbenzan-
thracene, which have a much more induc-
ing and carcinogenic potential (Buty et al.,
1976).
In our study, BP was injected i.p. into
the animals, either at a low dose (1 mg/kg)
or at a higher dose (80 mg/kg) which was
known to produce an optimal induction in
most of the tissues tested (Ciaccio & De
Vera, 1976).
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FIG. 4.-Influence of age on the induction
of AHH in the liver by low (1 mg/kg,
0) or high (80mg/kg, *) doses of BP.
(Controls, 0). Forexperimentalprocedures,
see legend to Fig. 2.
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FIG. 5.-Influence of age on the induction of
AHH in the kidney by low (1 mg/kg, 0)
or high (80 mg/kg, *) doses of BP. (Con-
trols, 0.) For experimental procedures, see
legend to Fig. 2.
Intheratliver, AHH activitywashighly
induced by the larger BP dose, regardless
ofthe age ofthe animal; with lower doses,
hepatic AHH activity was only signifi-
cantly induced in 15-day-old animals
(Fig. 4).
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FIG. 6.-Influence of age on the induction
of AHH in the lung by low (0) or high
(*) doses of BP (Controls, 0). For experi-
mental procedures, see legend to Fig. 2.
The phenomenon in the kidney was
identical: a high dose ofBP induced AHH
activity, whatever the age of the animal.
On the other hand, the enzyme was only
induced by a low dose of BP in young,
unweaned rats. In 15-day-old animals, we
even observed induction by a factor of 4,
but this effect rapidly diminished in older
rats (Fig. 5).
As with CSC, lung AHH responded to
BP injections entirely differently. Young
rats were nearly insensitive to BP injec-
tions, even at 80mg/kg doses, and AHH
inducibility increased with age to reach a
maximum in the adult animal. Low doses
of BP were then nearly as efficient in
inducing AHH activity as the 80mg/kg
dose. In 9-month-oldrats, lung AHH basal
activity decreased, but its inducibility
remained very pronounced (Fig. 6).
Ontogenetic variation in the induction of
ethoxycoumarin deethylase in the liver, and
in the induction of hepatic and extrahepatic
ethoxyresorufin deethylase afteri.p. injection
ofBP
As extrahepatic AHH belongs to the
class of monooxygenases with cytochrome
P1450 or P448 as a terminal oxidase, we
tested the action of BP on 2 other
microsomal monooxygenases linked to
this type of cytochrome; viz. ethoxy-
coumarin deethylase and ethoxyresorufin
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FIG. 7.-Influence of age on the induction of
ethoxycoumarin deethylase (A) andethoxy-
resorufin deethylase (B) in the liver by low
(0) or high (*) doses ofBP (Controls, 0).
For experimental procedures, see legend to
Fig. 2.
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Fic. 8.-Influence of age on the induction of
ethoxyresorufin deethylase in the kidney
and lung by low (0) or high (*) doses of
BP (Controls, 0). For experimental pro-
cedures, see legend to Fig. 2.
deethylase. These enzymes metabolize a
drug which is not a polycyclic hydrocar-
bon. As shown in Fig. 7, these enzymes
are induced only in 15-day-old rat liver
by low doses ofBP, whereas the induction
of these enzymes by high doses of BP was
possible at any age.
Unfortunately, in other tissues, ethoxy-
coumarin deethylase cannot be measured
by ourtechnique; onlyresultsfrom ethoxy-
resorufin deethylase assays can be pre-
sented.
In the kidney and lung, ethoxyresorufin
deethylase displays an inducibility that is
comparable to that of AHH (Fig. 8). In
the kidney, low-dose BP induces ethoxy-
resorufin deethylase activity only in
15-day-old rats. In the lung, the induci-
bility increases with age; it does not exist
in 15-day old rats, is 3-fold in 30-day-old
rats, and 5-fold in 3-month-old rats. In
all cases, the lmg/kg dose is as efficient
as the higher dose, both producing the
same effect.
Enzymes not induced by i.p. injections of
BP or CSC
We tested the effect of the same dose
(25 mg/kg) of either BP or CSC on some
enzymes currently assayed in our labora-
tory. This included microsomal mono-
oxygenases linked to cytochrome P450,
such as aldrin epoxidase, aminopyrine-N-
demethylase and benzphetamine-N-de-
methylase, as well as epoxide hydrolase
andepoxide-glutathione transferase,which
are both involved in the metabolism of
polycyclichydrocarbons. Alltheseenzymes
could be measured in the liver, kidney
and lung (with some difficulties for the
demethylases in extrahepatic tissues).
Nevertheless, none was modified by BP
or CSC, regardless of the tissue analysed
(data notshown).
Organ weight andprotein content at various
ages
Throughout this paper, AHH activities
are expressed in units per gram of tissue.
However, any other unit (e.g. per mg
protein) will give qualitatively similar
results, as protein content is hardly
influenced by the treatment or the age
ofthe animals (data not shown).
DISCUSSION
Numerous studies on rats (Welch et al.,
1971; Van Cantfort & Gielen, 1977) and
mice (Abramson & Hutton, 1975; Van
Cantfort & Gielen, 1975; Kouri et al.,
1974) have demonstrated that cigarette
smoke contains potent inducing agents
of lung and kidney AHH activity. Never-
theless, given the dose inhaled, the
kinetics of the AHH induction and the
organotropism, we previously postulated
that polycyclic hydrocarbons linked to
smoke could not be the main AHH-
inducing agents (Van Cantfort & Gielen,
1977). Kouri et al. (1974) demonstrated
that it was necessary to administer at
least 10 mg/kg of methylcholanthrene via
the trachea to induce pulmonary AHH in
the mouse, i.e. a dose which is 5000 x
that of CSC to give the same effect.
The experiments described in this paper
do not confirm this hypothesis, but on the
contrary, lead us to believe that the action
of low doses of polycyclic hydrocarbons
explains the induction observed after the
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inhalation of cigarette smoke. I.p. injec-
tion of CSC selectively induces pulmonary
and renal AHH in a manner similar to
that of the inhalation of smoke. This
experimental model is particularly easy
to control, and it is much easier to estab-
lish quantitative comparisons. Such a
study conducted on a small number of
animals (data not shown) shows that
similar inductions ofthe AHH activity are
obtained after i.p. injections of BP (0.1
mg/kg) or CSC (25 mg/kg). According to
Akin et al. (1976), 1 g of CSC contains
200 jug of polycyclic hydrocarbons and
5 Itg of BP. Thus, the total amount of
polycyclic hydrocarbons linked to CSC is
one-twentieth the amount of BP required
to produce the same induction. This quan-
titative difference can be explained in
several ways: (a) the existence of more
powerful inducers than the polycyclic
hydrocarbons in the CSC: (b) the existence
of polycyclic hydrocarbons which are
more powerful inducers than BP; (c) a
synergic effect of CSC constituents. The
parallel inducing effects of CSC and BP
as a function of the age of the animal and
the organ under investigation are an
additional biological argument for the
hypothesis that polycyclic hydrocarbons
play an important part in the inducing
action of CSC.
The age-related variation of the BP
induction of AHH activity in various
organs is surprising. In the liver and kid-
ney, the enzyme is inducible by a low dose
of BP only during a short period before
weaning. These results must be interpreted
on the basis of the multiplicity or speci-
ficity of microsomal monooxygenases (Ull-
rich & Kremers, 1977; Lu & Levin, 1974;
Nebert, 1979). These enzymes exist as
different molecular forms having variable
specificities towards substrates or the
position on these substrates (Nebert &
Jensen, 1979). They metabolize pesticides
and exogenous drugs, as well as steroids
or endogenous fatty acids (Nebert &
Jensen, 1979). Hence, the temporary AHH
inducibility during the development of
the animal could correspond to the
appearance of monooxygenases with a
physiological role in the maturation of the
organism during this period. This observa-
tion supports that of Atlas et al. (1977)
who demonstrated the existence of a
temporal control of the monooxygenases
linked to P450 and P1450 in the rabbit.
The non-induction bv low doses of CSC
and BP in the adult liver and kidney could
be explained by the presence of inducers
in the diet which would make the enzyme
refractory to additional induction. This
hypothesis would be difficult to reconcile
with the following observations: (1) the
kidney and liver AHH activities were well
induced by higher doses ofBP in the adult
animal and (2) the basal activity of the
lung enzyme decreased with the age of
the rat and responded to the lowest doses
ofthe inducers.
In the lung and with respect to carcino-
genesis, the increase in inducibility in
adult animals could correspond to a higher
risk factor. Moreover, the great sensitivity
of the lung to low doses of BP should be
related to the increase in the development
of lung cancer in smokers.
We believe that the special AHH
inducibility of the lung of the adult
animal is a very important biological fact;
our forthcoming studies should give us
insight into the cause and biological conse-
quences of this phenomenon.
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